38,768 Shares of HCA Healthcare, Inc. $HCA Bought by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA – Free Report) in the 3rd quarter, HoldingsChannel.com reports. The firm acquired 38,768 shares of the company’s stock, valued at approximately $16,544,000.

Several other hedge funds have also recently modified their holdings of the company. Cedar Mountain Advisors LLC bought a new position in shares of HCA Healthcare in the first quarter valued at approximately $33,000. MidFirst Bank bought a new stake in HCA Healthcare during the second quarter worth $28,000. Clearstead Trust LLC purchased a new position in HCA Healthcare in the second quarter worth $29,000. Latitude Advisors LLC purchased a new position in HCA Healthcare in the third quarter worth $32,000. Finally, Delos Wealth Advisors LLC bought a new position in HCA Healthcare in the 2nd quarter valued at $35,000. Institutional investors own 62.73% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on HCA shares. KeyCorp lifted their target price on HCA Healthcare from $435.00 to $490.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 28th. Mizuho set a $495.00 price target on shares of HCA Healthcare in a research report on Wednesday, October 28th. Oppenheimer decreased their price objective on shares of HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating for the company in a report on Monday, July 27th. Sanford C. Bernstein reiterated a “market perform” rating on shares of HCA Healthcare in a research note on Wednesday, July 15th. Finally, Bank of America increased their target price on shares of HCA Healthcare from $450.00 to $500.00 and gave the company a “neutral” rating in a research report on Wednesday, October 28th. Sixteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $480.13.

Check Out Our Latest Analysis on HCA

HCA Healthcare Stock Down 1.1%

HCA opened at $462.52 on Wednesday. The firm has a 50-day moving average price of $438.88 and a 200-day moving average price of $444.76. HCA Healthcare, Inc. has a twelve month low of $353.99 and a twelve month high of $556.52. The company has a market capitalization of $96.62 billion, a price-to-earnings ratio of 15.33, a PEG ratio of 1.56 and a beta of 1.11.

HCA Healthcare (NYSE:HCA – Get Free Report) last released its quarterly earnings data on Tuesday, October 27th. The company reported $7.22 EPS for the quarter, topping the consensus estimate of $6.65 by $0.57. HCA Healthcare had a net margin of 8.61% and a negative return on equity of 198.52%. The company had revenue of $19.85 billion during the quarter, compared to the consensus estimate of $19.33 billion. During the same period last year, the firm earned $6.96 EPS. HCA Healthcare’s revenue for the quarter was up 3.6% on a year-over-year basis. On average, sell-side analysts expect that HCA Healthcare, Inc. will post 30.15 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 29th. Investors of record on Tuesday, December 15th will be paid a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, December 15th. This represents a $3.12 annualized dividend and a yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.34%.

Trending Headlines about HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

  • Positive Sentiment: Truist reaffirmed its “Buy” rating and raised its price target to $510 from $495, suggesting confidence in HCA’s prospects. Read More.
  • Positive Sentiment: HCA plans a $300 million hospital in Cape Coral, Florida, with $31 million in city incentives. The project could support future capacity and growth, though it also entails significant investment. Cape Coral hospital article
  • Neutral Sentiment: An HCA subsidiary plans to issue senior notes. The financing may support corporate needs, but the available report does not provide terms or indicate how much debt will be added. Senior notes offering
  • Negative Sentiment: A report on HCA’s third-quarter payer mix highlights an estimated $400 million cost burden associated with a shift toward uninsured patients. Higher uncompensated-care costs could weigh on margins. Q3 revenue by payer article
  • Negative Sentiment: Pomerantz LLP said it is investigating potential claims on behalf of HCA investors. An investigation is not a finding of wrongdoing, but the announcement adds legal and reputational uncertainty. Investor investigation announcement
  • Negative Sentiment: A reported data breach affected about 55,000 people, creating potential privacy, remediation and reputational risks. Data breach report

HCA Healthcare Profile

(Free Report)

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.

Read More

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.